Article
Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
12 May 2021
Abstract excerpt
BACKGROUND: The global health emergency of COVID-19 has necessitated the development of multiple therapeutic modalities including vaccinations, antivirals, anti-inflammatory, and cytoimmunotherapies, etc. COVID-19 patients suffer from damage to various organs and vascular structures, so they present multiple health crises. Mesenchymal stem cells (MSCs) are of interest to treat acute respiratory distress syndrome...
Topics
Join the communities discussing this publication.